KP

Kamleshkumar Pandey

Director DIN 05317956
DIN 05317956 First appointment Jul 2012
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Kamleshkumar Pandey

Data last updated:

Kamleshkumar Pandey was a Director at Makoy Pharmaceutical Private Limited (from 2017) and Director at Biozen Remedies Private Limited (from 2012).

DIN 05317956
First Appointment 23 Jul 2012
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Makoy Pharmaceutical Private Limited U24304MH2017PTC291810
Director28 Feb 20172017Strike Off
Biozen Remedies Private Limited U24233MH2012PTC233682
Director23 Jul 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Makoy Pharmaceutical Private Limited
Biozen Remedies Private Limited
Premium access

Shareholding and investment profile for Kamleshkumar Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamleshkumar Pandey

Kamleshkumar Pandey was first appointed on 23 Jul 2012 as Director at Biozen Remedies Private Limited. The most recent appointment on record is 28 Feb 2017 at Makoy Pharmaceutical Private Limited.

Kamleshkumar Pandey held 2 earlier board appointments: Makoy Pharmaceutical Private Limited (Director, from 28 Feb 2017); Biozen Remedies Private Limited (Director, from 23 Jul 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available